Group 1 - The announcement from the National Medical Products Administration supports significant innovation in high-end medical devices, focusing on core technologies such as brain-computer interfaces, artificial intelligence, and medical robots [1][2] - The announcement outlines key areas for development, including medical robots, high-end medical imaging equipment, AI medical devices, and new biological materials, and proposes measures to optimize approval processes and enhance regulatory frameworks [2][3] - The high-end medical device market in China is expanding, with an average annual growth rate exceeding 20%, particularly in areas like medical robots and AI medical devices, which are experiencing explosive growth [3][4] Group 2 - Companies are actively advancing technology applications in high-end medical devices, with many listed firms strategically positioning themselves in AI and medical robotics to seize development opportunities [4] - Several companies have developed innovative products, such as the ZAP-X radiation surgery robot and a fully magnetic levitation artificial heart, indicating a trend towards high-quality development in the sector [4] - Collaboration between companies, medical institutions, and research organizations is emphasized to accelerate the transformation of research results into market-ready products [4]